Opinion

Video

How HER2 Targeted Therapies Fight HER2-Positive Metastatic Breast Cancer

Author(s):

Sara M. Tolaney, MD, MPH

HER2-targeted therapies improve outcomes by shutting down growth signaling to cancer cells, targeted delivery of chemotherapy, or blocking intracellular signaling - all leveraging the HER2 receptor to better control metastatic breast cancer.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Photo of Hideko Warner
Picture of LaShae D. Rolle
Photo of Jake Messier
Related Content
Breast cancer types, staging, genetics, diagnosis, treatment, and survivorship are complex, but understanding them helps patients make informed care decisions.
August 23rd 2025

Breast Cancer: What You Need to Know About Types, Staging and Genetics

Spencer Feldman
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
August 23rd 2025

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
Image of Debbie.
August 23rd 2025

How My Daughter’s Cancer Team Helped Me Stay Her Mom

Debbie Legault
Cancer Horizons podcast logo
August 23rd 2025

Conference Highlights from SABCS

Alex Biese Brielle Benyon
Study finds anti-nausea drug aprepitant boosts distant disease-free and breast cancer-specific survival in early-stage triple-negative breast cancer: © stock.adobe.com.
August 23rd 2025

Can Aprepitant Improve Survival for Women With Breast Cancer?

Spencer Feldman
Structured resistance training is safe for breast cancer patients: © vitanovski - stock.adobe.com.
August 23rd 2025

Is Resistance Training Safe for Patients With Breast Cancer?

Spencer Feldman